http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0285906-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275
filingDate 1988-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1993-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0285906-B1
titleOfInvention Active agent for combating tumours
abstract The use of norverapamil alone or in combination with carcinostatics in tumour therapy is described.
priorityDate 1987-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226575014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135773392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129233874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID327044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136039236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID457193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129654227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136050722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136126664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226443603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129400054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129382061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9554281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135789409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129320636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128886972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163659
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18183743

Total number of triples: 61.